CD8+ T-Cell Responses Identify β-Cell Autoimmunity in Human Type 1 Diabetes

Explore this paper's citation graph

Summary

The ISL8Spot assay is capable of detecting and quantifying β-cell–reactive CD8+ T-cells directly ex vivo, without any preliminary expansion, using either fresh or frozen samples, and may open new avenues toward type 1 diabetes prediction and prevention.

Type
article
Published
2007-03-01
Cited by
148
References
54
Access
Open access

Keywords

Computer science

References

Cited by

Related papers

No related papers recorded.